Global Rapid Microbiology Detection Market Growth (Status and Outlook) 2024-2030
Based on method, the global rapid microbiology detection market is divided into five segments growth-based, viability-based, cellular component- based, nucleic acid-based, and Others testing methods. The growth-based rapid microbiology detection segment is expected to account for the largest share of the market in 2018.
The global Rapid Microbiology Detection market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Rapid Microbiology Detection Industry Forecast” looks at past sales and reviews total world Rapid Microbiology Detection sales in 2023, providing a comprehensive analysis by region and market sector of projected Rapid Microbiology Detection sales for 2024 through 2030. With Rapid Microbiology Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Microbiology Detection industry.
This Insight Report provides a comprehensive analysis of the global Rapid Microbiology Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Microbiology Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Microbiology Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Microbiology Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Microbiology Detection.
The rapid microbiology detection market, by end user, is segmented into diagnostic laboratories & hospitals, food & beverage companies, pharmaceutical companies, CROs, and Others end users. In 2018, the diagnostic laboratories & hospitals segment is expected to account for the largest share of the rapid microbiology detection market. Some of the key factors driving the growth of this segment are the increasing prevalence of infectious diseases, improving healthcare expenditure, and technological advancements in rapid microbial testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Microbiology Detection market by product type, application, key players and key regions and countries.
Segmentation by type
Growth-Based
Viability-Based
Cellular Component-Based
Nucleic Acid-Based
Others
Segmentation by application
Diagnostic Laboratories & Hospitals
Pharmaceutical & Biotechnology Companies
Food & Beverage Companies
Contract Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
BD
Merck
Bruker
Danaher
Thermo Fisher Scientific
Biomerieux
Charles River Laboratories
Neogen
TSI
Quidel Corporation
Vivione Biosciences
Please note: The report will take approximately 2 business days to prepare and deliver.